Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on May 19, 2015, 12:50:07 pm
-
Tell this to your insurance company:
A new study on the financial effects of Harvoni has found that treating all people with hepatitis C virus in the United States and five Western European nations could lead an economic benefit to the tune of $3.2 billion per year.
The study participants responded to questionnaires, reporting on things like workplace absenteeism and productivity. To check out more info about the real-world benefits of treatment:
http://www.hepmag.com/articles/economic_benefit_2501_27251.shtml